Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma.

Cecilia Monge BonillaChangqing XieSeth M SteinbergTim F Greten

Published in: Journal of hepatocellular carcinoma (2021)

We found a possible association between immune-related adverse events grade 3 and 4 and long-term survival in patients with advanced HCC. The cases in our analysis represent extraordinary defiance of the usual predicted dismal course of advanced HCC.

Keyphrases

stem cells
mesenchymal stem cells
chemotherapy induced